Levels of (1→3)-β-D-glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candida species

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Mokaddas, Eiman ^a   Burhamah, Mona H A ^b   Khan, Zia U ^a   Ahmad, Suhail ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b AL SABAH HOSPITAL   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,3 GLUCAN; FUNGAL DNA; MANNAN; BETA GLUCAN; BETA-1,3-D-GLUCAN; RIBOSOMAL SPACER DNA;

ARTICLE; AXILLA; CANCER PATIENT; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; CANDIDEMIA; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA DETERMINATION; DNA SEQUENCE; ENZYME BLOOD LEVEL; FUNGAL COLONIZATION; FUNGUS CULTURE; FUNGUS ISOLATION; HUMAN; INGUINAL REGION; MAJOR CLINICAL STUDY; NONHUMAN; NOSE SMEAR; NUCLEOTIDE SEQUENCE; OROPHARYNX; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; RECTUM; SPECIES DIFFERENCE; ADOLESCENT; BLOOD; CANDIDA; CANDIDIASIS; CLASSIFICATION; INFANT; ISOLATION AND PURIFICATION; LEUKEMIA; MICROBIOLOGY; PRESCHOOL CHILD;

ADOLESCENT; BETA-GLUCANS; CANDIDA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; DNA, FUNGAL; DNA, RIBOSOMAL SPACER; HUMANS; INFANT; LEUKEMIA; MANNANS; POLYMERASE CHAIN REACTION;

EID: 77957294956     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-292     Document Type: Article

References (38)

1. Kobayashi R, Kaneda M, Sato T, Ichikawa M, Suzuki D, Ariga T. The clinical feature of invasive fungal infection in pediatric patients with hematologic and malignant diseases: a 10-year analysis at a single institution at Japan. J Pediatr Hematol Oncol 2008, 30:886-890. 10.1097/MPH.0b013e3181864a80, 19131772.
2. Lockhart SR, Diekemas DJ, Pfaller MA. The epidemiology of fungal infections. Clinical Mycology 2009, 1-14. Churchill-Livingstone, Elsevier, Anaissie EJ, McGinnis MR, Pfaller MA, 2.
3. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007, 20:133-163. 10.1128/CMR.00029-06, 1797637, 17223626.
4. Clark TA, Hajjeh RA. Recent trends in the epidemiology of invasive mycoses. Curr Opin Infect Dis 2002, 15:569-574.
5. Michallet M, Ito JI. Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantation. J Clin Oncol 2009, 27:3398-3409. 10.1200/JCO.2008.20.1178, 19487382.
6. Charles PE. Multifocal Candida species colonization as a trigger for early antifungal therapy in critically ill patients: what about other risk factors for fungal infection?. Crit Care Med 2006, 34:913-914. 10.1097/01.CCM.0000202435.98240.ED, 16505683.
7. Maertens J, Theunissen K, Verhoef G, Verschakelen J, Lagrou K, Verbeken E, Wilmer A, Verhaegen J, Boogaerts M, Van Eldere J. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 2005, 41:1242-1250. 10.1086/496927, 16206097.
8. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003, 3:685-702. 10.1016/S1473-3099(03)00801-6, 14592598.
9. León C, Ruiz-Santana S, Saavedra P, Galván B, Blanco A, Castro C, Balasini C, Utande-Vázquez A, González de Molina FJ, Blasco-Navalproto MA, López MJ, Charles PE, Martín E, Hernández-Viera MA, . Cava Study Group Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 2009, 37:1624-1633. 10.1097/CCM.0b013e31819daa14, 19325481, Cava Study Group.
10. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994, 220:751-758. 10.1097/00000658-199412000-00008, 1234477, 7986142.
11. Sandford GR, Merz WG, Wingard JR, Charache P, Saral R. The value of fungal surveillance cultures as predictors of systemic fungal infections. J Infect Dis 1980, 142:503-509.
12. Alam FF, Mustafa AS, Khan ZU. Comparative evaluation of (1, 3)-β-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia. BMC Infect Dis 2007, 7:103-112. 10.1186/1471-2334-7-103, 2075513, 17784947.
13. Ellis M, Al-Ramadi B, Bernsen R, Kristensen J, Alizadeh H, Hedstrom U. Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever. J Med Microbiol 2009, 58:606-615. 10.1099/jmm.0.006452-0, 19369522.
14. Nakamura A, Ishikawa N, Suzuki H. Diagnosis of invasive candidiasis by detection of mannan antigen by using the avidin-biotin enzyme immunoassay. J Clin Microbiol 1991, 29:2363-2367. 270339, 1774238.
15. Hedderwick SA, Lyons MJ, Liu M, Vazquez JA, Kauffman CA. Epidemiology of yeast colonization in the intensive care unit. Eur J Clin Microbiol Infect Dis 2000, 19:663-670. 10.1007/s100960000348, 11057499.
16. Ahmad S, Khan Z, Mustafa AS, Khan ZU. Seminested PCR in the diagnosis of candidemia: comparison with culture, antigen detection, and biochemical methods for identification. J Clin Microbiol 2002, 40:2483-2489. 10.1128/JCM.40.7.2483-2489.2002, 120535, 12089267.
17. Ahmad S, Mustafa AS, Khan Z, Rifaiy A, Khan ZU. PCR-enzyme immunoassay for rDNA in the diagnosis of candidemia and comparison with amplicon detection by agarose gel electrophoresis. Int J Med Microbiol 2004, 294:45-51. 10.1016/j.ijmm.2004.01.002, 15293453.
18. Ahmad S, Khan Z, Mokaddas E, Khan ZU. Isolation and molecular identification of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Kuwait. J Med Microbiol 2004, 53:633-637. 10.1099/jmm.0.05315-0, 15184534.
19. Khan ZU, Mustafa AS. Detection of Candida species by polymerase chain reaction (PCR) in blood samples of experimentally infected mice and patients with suspected candidemia. Microbiol Res 2001, 156:95-102. 10.1078/0944-5013-00072, 11372661.
20. Al-Sweih N, Ahmad S, Khan ZU, Khan S, Chandy R. Prevalence of Candida dubliniensis among germ tube-positive Candida isolates in a maternity hospital in Kuwait. Mycoses 2005, 48:347-351. 10.1111/j.1439-0507.2005.01143.x, 16115107.
21. Ahmad S, Al-Mahmeed M, Khan ZU. Characterization of Trichosporon species isolated from clinical specimens in Kuwait. J Med Microbiol 2005, 54:639-646. 10.1099/jmm.0.45972-0, 15947428.
22. Khan ZU, Ahmad S, Mokaddas E, Chandy R, Cano J, Guarro J. Actinomucor elegans var. kuwaitiensis isolated from the wound of a diabetic patient. Antonie van Leeuwenhoek 2008, 94:343-352. 10.1007/s10482-008-9251-1, 18496764.
23. Lai YY, Bao L, Lu XJ, Lu J, Yu J, Li RY, Huang XJ. Candida colonization and invasive fungal infection in hospitalized patients with hematological malignancies. Zhonghua Yi Xue Za Zhi 2009, 89:239-242.
24. Ellis M, Al-Ramadi B, Finkelman M, Hedstrom U, Kristensen J, Ali-Zadeh H, Klingspor L. Assessment of the clinical utility of serial β-D-glucan concentrations in patients with persistent neutropenic fever. J Med Microbiol 2008, 57:287-295. 10.1099/jmm.0.47479-0, 18287290.
25. Odabasi Z, Mattiuzzi G, Estey E, Kantarjian H, Saeki F, Ridge RJ, Ketchum PA, Finkelman MA, Rex JH, Ostrosky-Zeichner L. β-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004, 39:199-205. 10.1086/421944, 15307029.
26. Obayashi T, Yoshida M, Mori T, Goto H, Yasuoka A, Iwasaki H, Teshima H, Kohno S, Horiuchi A, Ito A, Yamaguchi H, Shimada K, Kawai T. Plasma (13)-β-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995, 345:17-20. 10.1016/S0140-6736(95)91152-9, 7799700.
27. Pazos C, Pontón J, Del Palacio A. Contribution of (1-3)-β-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 2005, 43:299-305. 10.1128/JCM.43.1.299-305.2005, 540165, 15634986.
28. Kato A, Takita T, Furuhashi M, Takahashi T, Maruyama Y, Hishida A. Elevation of blood (13)- β-D-glucan concentrations in hemodialysis patients. Nephron 2001, 89:15-19. 10.1159/000046037, 11528226.
29. Nakao A, Yasui M, Kawagoe T, Tamura H, Tanaka S, Takagi H. False-positive endotoxemia derives from gauze glucan after hepatectomy for hepatocellular carcinoma with cirrhosis. Hepatogastroenterology 1997, 44:1413-1418.
30. Digby J, Kalbfleisch J, Glenn A, Larsen A, Browder W, Williams D. Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol 2003, 10:882-885. 193887, 12965921.
31. Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL. Evaluation of a (1-3)- β-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2005, 43:5957-5962. 10.1128/JCM.43.12.5957-5962.2005, 1317189, 16333082.
32. Mennink-Kersten MA, Warris A, Verweij PE. 1,3-β-D-glucan in patients receiving intravenous amoxicillin-clavulanic acid. N Engl J Med 2006, 354:2834-2835. 10.1056/NEJMc053340, 16807428.
33. Akamatsu N, Sugawara Y, Kaneko J, Tamura S, Makuuchi M. Preemptive treatment of fungal infection based on plasma (1-3)- β-D-glucan levels after liver transplantation. Infection 2007, 35:346-351. 10.1007/s15010-007-6240-7, 17885729.
34. Senn L, Robinson JO, Schmidt S, Knaup M, Asahi N, Satomura S, Matsuura S, Duvoisin B, Bille J, Calandra T, Marchetti O. 1,3-β-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 2008, 46:878-885. 10.1086/527382, 18260755.
35. Ostrosky-Zeichner L, Alexander BD, Kett DH, Vazquez J, Pappas PG, Saeki F, Ketchum PA, Wingard J, Schiff R, Tamura H, Finkelman MA, Rex JH. Multicenter clinical evaluation of the (13)-β-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005, 41:654-659. 10.1086/432470, 16080087.
36. Marty FM, Koo S. Role of (13)-β-D-glucan in the diagnosis of invasive aspergillosis. Med Mycol 2009, 47(Suppl 1):233-240.
37. Wheat LJ. Approach to the diagnosis of invasive aspergillosis and candidiasis. Clin Chest Med 2009, 30:367-377. 10.1016/j.ccm.2009.02.012, 19375641.
38. Smith PB, Benjamin DK, Alexander BD, Johnson MD, Finkelman MA, Steinbach WJ. Quantification of 1,3-β-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting. Clin Vaccine Immunol 2007, 14:924-925. 10.1128/CVI.00025-07, 1951061, 17538119.